产品介绍 评论(0)
物种
Human分子别名
AHUS2, MCP, MIC10, TLX, TRA2.10Accession
P15529-3表达序列
Cys35-Asp328 with His Tag at the C-Terminus
表达宿主
HEK293分子量
55-70kDa (Reducing)纯度
>95% by SDS-PAGE & HPLC活性
Immobilized CD46 His Tag Protein, Human (Cat. No. UA016145) at 1.0 μg/mL (100 μL/well) can bind FG-3246(FOR46) with EC50 of 0.43-0.71 ng/mL.标记
Unconjugated标签
His Tag性状
Lyophilized Powder缓冲体系
PBS, pH7.4, 5% trehalose
溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.储存条件
· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.文献引用
1. AGGARWAL R R, VUKY J, VANDERWEELE D, et al. Phase I, first-in-human study of FOR46 (FG-3246), an immune-modulating antibody-drug conjugate targeting CD46, in patients with metastatic castration-resistant prostate cancer[J]. Journal of Clinical Oncology, 2025, 43(15): 1824-1834.
2. LISZEWSKI M K, ATKINSON J P. The multiverse of CD46 and oncologic interactions[J]. Journal of Clinical Investigation, 2025, 135(9): e188355.
3. BIDKAR A P, PETER R, WADHWA A, et al. Effective treatment of disseminated prostate cancer using CD46-targeted 225Ac therapy[J]. Clinical Cancer Research, 2025, 31(14): 2963-2977.
CD46, also known as complement regulatory protein or membrane cofactor protein (MCP), is a type I transmembrane glycoprotein widely expressed on human cell surfaces. Its structure comprises four complement control protein repeats (CCPs), a serine/threonine-rich region, a transmembrane domain, and a cytoplasmic tail, with multiple isoforms generated through alternative splicing. The core function of CD46 lies in its role as a key regulator of the complement system, where it serves as a cofactor for the proteolytic cleavage of C3b/C4b by factor I, thereby protecting host cells from complement-mediated cytolysis. Additionally, CD46 acts as a cellular receptor for various pathogens, including measles virus and adenovirus, and participates in modulating T cell metabolism and immune responses. In recent years, CD46 has emerged as a promising therapeutic target in oncology due to its overexpression in multiple solid tumors—such as prostate, bladder, and multiple myeloma—spurring the clinical development of antibody-drug conjugates (ADCs), targeted alpha-particle radiotherapy, and theranostic strategies, all demonstrating favorable therapeutic potential.
电泳
2μg (R: reducing condition, N:non-reducing condition).
体积排阻色谱(SEC-HPLC)
The purity of CD46 His Tag Protein, Human is more than 95% determined by SEC-HPLC.
ELISA
Immobilized CD46 His Tag Protein, Human (Cat. No. UA016145) at 1.0 μg/mL (100 μL/well) can bind FG-3246(FOR46) with EC50 of 0.43-0.71 ng/mL.







评论(0)